SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001626129-17-000278
Filing Date
2017-04-21
Accepted
2017-04-21 16:23:33
Documents
2
Effectiveness Date
2017-04-21

Document Format Files

Seq Description Document Type Size
1 cgix-defa14a_060717.htm DEFA14A 68212
2 GRAPHIC cgixdefa14a001.jpg GRAPHIC 3207
  Complete submission text file 0001626129-17-000278.txt   73884
Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070
Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200
CANCER GENETICS, INC (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35817 | Film No.: 17776188
SIC: 8071 Services-Medical Laboratories